Delivery Order SPE2DB25D3504-SPE2DB25FVUFX

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,000.87 firm fixed-price delivery order is for the supply of 4,567,796,172 capsules of 200 mg progesterone. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $19,240.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of 200 mg progesterone capsules. It is a non-set-aside contract, meaning it was open to all eligible vendors. The contract has an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,019.55 firm fixed-price delivery order is for the supply of 4566831843 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. There was no set-aside designation used for this award. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,560.45, is for the delivery of Progesterone 100 mg Capsules in quantities of 100s. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,456.09, is a delivery order for the supply of 4567726860 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of March 31, 2025 and uses a firm fixed price pricing type. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,286.65 firm fixed price delivery order is for the supply of 4,567,118,682 units of Progesterone 100 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,611,389 units of 200 mg progesterone capsules in 100-count bottles, with a ceiling value of $6,899.45. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 milligram Progesterone capsules, with a ceiling value of $1,017.69 and a performance period ending on May 20, 2025. The contract is not set aside and allows for the delivery of both brand-name and generic medications to support federal medical requirements....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,267,269 units of Progesterone 100 mg capsules in 100s, with a firm fixed price of $2,904.76 and a completion date of February 14, 2025. The contract is a Delivery Order, which indicates it is part of a larger Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.82 contract is for the delivery of 4,567,961,993 units of the 200 mg progesterone capsule. The award has no set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUFX
    Delivery Order

This is a $1,860.98 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,910,087 units of Progesterone 100 mg capsules, with a completion date of April 15, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 7/14/25, 10:49 AM